Empowered Funds’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.76M Buy
679,790
+36,529
+6% +$243K 0.03% 651
2026
Q1
$3.51M Sell
643,261
-99,044
-13% -$556K 0.02% 805
2025
Q4
$5.2M Buy
742,305
+14,029
+2% +$110K 0.09% 244
2025
Q3
$5.63M Buy
728,276
+149,587
+26% +$1.17M 0.06% 446
2025
Q2
$5.04M Buy
+578,689
New +$4.19M 0.06% 435
2020
Q3
Sell
-7,890
Closed -$1.51M 154
2020
Q2
$1.51M Buy
+7,890
New +$1.38M 0.58% 58
2019
Q2
Sell
-21,511
Closed -$1.2M 117
2019
Q1
$1.2M Buy
21,511
+672
+3% +$41K 0.43% 93
2018
Q4
$1.03M Sell
20,839
-1,664
-7% -$102K 0.44% 89
2018
Q3
$1.86M Buy
+22,503
New +$1.6M 0.55% 53

Other funds holding TDOC

Empowered Funds's TDOC Position: Q2 2026 in Review

Empowered Funds increased its Teladoc Health (TDOC) stake by 5.7% in Q2 2026, buying an estimated $243K and bringing the position to 679,790 shares worth $5.76M. The position accounts for 0.03% of the portfolio, ranked #651.

Empowered Funds first reported a position in TDOC in Q3 2018 and has held it in 9 quarters since. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Empowered Funds held 679,790 shares of Teladoc Health worth $5.76M as of Q2 2026.
  • Empowered Funds bought 36,529 Teladoc Health shares in Q2 2026, an estimated $243K.
  • Teladoc Health made up 0.03% of Empowered Funds's portfolio in Q2 2026, its #651 holding.
  • Empowered Funds first reported a position in Teladoc Health in Q3 2018 and has held it in 9 quarters since.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.